Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced peripheral neuropathy (CIPN). CIPN is associated with psychological distress and a decrease of health-related quality of life (HRQoL), but lit...
Saved in:
Main Authors: | Marie Selvy (Author), Nicolas Kerckhove (Author), Bruno Pereira (Author), Fantine Barreau (Author), Daniel Nguyen (Author), Jérôme Busserolles (Author), Fabrice Giraudet (Author), Aurélie Cabrespine (Author), Carine Chaleteix (Author), Martin Soubrier (Author), Jacques-Olivier Bay (Author), Richard Lemal (Author), David Balayssac (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy
by: Nicolas Kerckhove, et al.
Published: (2021) -
Chronic demyelinating polyneuropathy associated with anti-ganglioside GQ1b antibodies in peripheral T-cell lymphoma
by: Salem Bahashwan, et al.
Published: (2019) -
Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies
by: Edouard Montigné, et al.
Published: (2023) -
Intervention strategies to promote healthy and sustainable food choices among parents with lower and higher socioeconomic status
by: Marjolijn Vos, et al.
Published: (2022) -
Use of Psychotropic Medications and Illegal Drugs, and Related Consequences Among French Pharmacy Students - SCEP Study: A Nationwide Cross-Sectional Study
by: David Balayssac, et al.
Published: (2018)